Sort
261,768 grants matching “gene therapy”
University of Washington Obstetric-fetal Pharmacology Research Unit
$1,002,006Mary F Hebert · University Of Washington · U10 · FY2010 · HD
Oscillated Insertion Tool for Minimally Invasive, Low-Damage, Accurate Placement of Delivery Cannula to Improve Efficacy for DREADDS Therapy in Alcohol Addiction Treatment
$1,001,961Roger Brooks Bagwell · Actuated Medical, Inc. · R44 · FY2024 · AA
A Novel Immunological-Directed Live Biotherapy Product for Treating Ulcerative Colitis
$1,001,952Gary Fanger · Rise Therapeutics, Llc · R44 · FY2023 · DK
Development of a small molecule activator of integrin cell adhesion to enhance therapeutic responses to checkpoint blockade in cancer
$1,001,898Upendra Marathi · 7 Hills Pharma, Llc · R42 · FY2019 · CA
HIV-1 Maturation
$1,001,849Eric Freed · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Center for Gene Therapy of Cystic Fibrosis and Other Ge*
$1,001,840John F Engelhardt · University Of Iowa · P30 · FY2007 · DK
Sequencing Technology Core
$1,001,799Donna Muzny · Baylor College Of Medicine · U19 · FY2019 · AI
Preclinical Development of an NT3-expressing HSV Vector
$1,001,774David J. Fink · University Of Michigan At Ann Arbor · U01 · FY2011 · NS
Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy
$1,001,634Martin W Brechbiel · Division Of Clinical Sciences - Nci · ZIA · FY2015 · CA
Informative Clinical Studies in Asthma
$1,001,474Brigham And Women'S Hospital · U10 · FY2005 · HL
Development of a first-in-class therapeutic for producing 'on-demand' voiding
$1,001,467Karl B Thor · Dignify Therapeutics, Llc · R44 · FY2018 · DK
Dynamics and Genetics of HIV Proviruses before and during Antiretroviral Therapy
$1,001,426Mary Kearney · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Novel and functionally selective 5-HT2C receptor agonist for treating Alcohol Use Disorder
$1,001,425Jeremy Forest · Kuleon Llc · U43 · FY2025 · AA
Microfluidic cell squeezing platform for the transdifferentiation of somatic cells for efficient generation of a cell replacement therapy for Parkinsons Disease
$1,001,356Devin Bridgen · Sqz Biotechnologies Company, Inc. · R44 · FY2022 · GM
Proof of Principle Evaluation of IV Gallium Nitrate in Patients with CF
$1,001,346Christopher Hooper Goss · University Of Washington · UM1 · FY2013 · HL
Cell-free assay technologies for the identification of active compounds
$1,001,166Barry Okeefe · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Clinical production of viral vectors for cancer gene therapy
$1,001,150Steven Feldman · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA
Identification of radiosensitizers for prostate cancer
$1,001,043Travis Stracker · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Discovering mechanisms of neuroblastoma tumorigenesis to improve patient outcomes
$1,001,040John M Maris · Children'S Hosp Of Philadelphia · R35 · FY2019 · CA
Development of CD4 TCR-engineered T cell immunotherapy in triple-negative breast cancer
$1,001,029Yicheng Wang · Immunova Therapeutics, Llc · R44 · FY2024 · CA
Small Molecule Inhibitors of HIV1 Nef Virulence Factor for Treatment of HIV_AIDS
$1,001,024Thomas Edward Smithgall · Fox Chase Chemical Diversity Center, Inc · R42 · FY2016 · GM
Age-Related Macular Degeneration: Genetic Variations and Animal Model
$1,000,820Chi-Chao Chan · National Eye Institute · ZIA · FY2012 · EY
DT-EGF Toxic Fusion Protein for the Treatment of Bladder Cancer
$1,000,745Mike Glode · Aurora Oncology, Inc. · R44 · FY2020 · CA
Endothelial Dysfunction, Biomarkers and Lung Function
$1,000,726Columbia University Health Sciences · R01 · FY2004 · HL
Stem Cell Biology, Cancer Stem Cell Biology, and Cancer Immunotherapy
$1,000,669Irving Lerner Weissman · Stanford University · R35 · FY2023 · CA